Global Plasma Protein Therapeutics Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Plasma Protein Therapeutics market size will reach 40,062 Million USD in 2025 and is projected to reach 67,994 Million USD by 2032, with a CAGR of 7.85% (2025-2032). Notably, the China Plasma Protein Therapeutics market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Plasma protein therapeutics refers to a category of medical treatments derived from human plasma proteins, which are isolated and purified to produce therapeutic products. These proteins play essential roles in various physiological processes, and when deficient or dysfunctional, they can lead to medical conditions. Plasma protein therapeutics include a range of products such as clotting factors for hemophilia, immunoglobulins for immune disorders, albumin for maintaining blood volume, and other proteins involved in coagulation and immune response. These therapies are typically administered through intravenous infusion to patients with congenital or acquired disorders affecting the production or function of specific proteins. Plasma protein therapeutics have revolutionized the treatment of various rare diseases, providing life-saving and life-sustaining interventions for individuals with conditions that were once challenging to manage effectively. The production of these therapeutics involves the plasma fractionation process, where plasma is separated into its constituent parts, and specific proteins are isolated and purified for therapeutic use.
The major global suppliers of Plasma Protein Therapeutics include Shire (Baxalta), CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Kamada, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Plasma Protein Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Plasma Protein Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Plasma Protein Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Plasma Protein Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Plasma Protein Therapeutics Include:
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada
Plasma Protein Therapeutics Product Segment Include:
Coagulation Factor
Immune Globulin
Albumin
Others
Plasma Protein Therapeutics Product Application Include:
Hemophilia
Pelvic inflammatory disease (PID)
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Plasma Protein Therapeutics Industry PESTEL Analysis
Chapter 3: Global Plasma Protein Therapeutics Industry Porter's Five Forces Analysis
Chapter 4: Global Plasma Protein Therapeutics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Plasma Protein Therapeutics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Plasma Protein Therapeutics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Plasma Protein Therapeutics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Plasma Protein Therapeutics market size will reach 40,062 Million USD in 2025 and is projected to reach 67,994 Million USD by 2032, with a CAGR of 7.85% (2025-2032). Notably, the China Plasma Protein Therapeutics market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Plasma protein therapeutics refers to a category of medical treatments derived from human plasma proteins, which are isolated and purified to produce therapeutic products. These proteins play essential roles in various physiological processes, and when deficient or dysfunctional, they can lead to medical conditions. Plasma protein therapeutics include a range of products such as clotting factors for hemophilia, immunoglobulins for immune disorders, albumin for maintaining blood volume, and other proteins involved in coagulation and immune response. These therapies are typically administered through intravenous infusion to patients with congenital or acquired disorders affecting the production or function of specific proteins. Plasma protein therapeutics have revolutionized the treatment of various rare diseases, providing life-saving and life-sustaining interventions for individuals with conditions that were once challenging to manage effectively. The production of these therapeutics involves the plasma fractionation process, where plasma is separated into its constituent parts, and specific proteins are isolated and purified for therapeutic use.
The major global suppliers of Plasma Protein Therapeutics include Shire (Baxalta), CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Kamada, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Plasma Protein Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Plasma Protein Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Plasma Protein Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Plasma Protein Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Plasma Protein Therapeutics Include:
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada
Plasma Protein Therapeutics Product Segment Include:
Coagulation Factor
Immune Globulin
Albumin
Others
Plasma Protein Therapeutics Product Application Include:
Hemophilia
Pelvic inflammatory disease (PID)
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Plasma Protein Therapeutics Industry PESTEL Analysis
Chapter 3: Global Plasma Protein Therapeutics Industry Porter's Five Forces Analysis
Chapter 4: Global Plasma Protein Therapeutics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Plasma Protein Therapeutics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Plasma Protein Therapeutics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Plasma Protein Therapeutics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Plasma Protein Therapeutics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Plasma Protein Therapeutics Product by Type
- 1.2.1 Coagulation Factor
- 1.2.2 Immune Globulin
- 1.2.3 Albumin
- 1.2.4 Others
- 1.3 Plasma Protein Therapeutics Product by Application
- 1.3.1 Hemophilia
- 1.3.2 Pelvic inflammatory disease (PID)
- 1.3.3 Others
- 1.4 Global Plasma Protein Therapeutics Market Size Analysis (2020-2032)
- 1.5 Plasma Protein Therapeutics Market Development Status and Trends
- 1.5.1 Plasma Protein Therapeutics Industry Development Status Analysis
- 1.5.2 Plasma Protein Therapeutics Industry Development Trends Analysis
- 2 Plasma Protein Therapeutics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Plasma Protein Therapeutics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Plasma Protein Therapeutics Market Analysis by Country
- 4.1 Global Plasma Protein Therapeutics Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Plasma Protein Therapeutics Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Plasma Protein Therapeutics Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.5 China Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.6 France Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.14 India Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Plasma Protein Therapeutics Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Plasma Protein Therapeutics Market Revenue by Key Suppliers (2021-2025)
- 5.2 Plasma Protein Therapeutics Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Plasma Protein Therapeutics Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Plasma Protein Therapeutics Market Analysis by Type
- 6.1 Global Plasma Protein Therapeutics Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Plasma Protein Therapeutics Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Shire (Baxalta)
- 7.1.1 Shire (Baxalta) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Shire (Baxalta) Plasma Protein Therapeutics Product Portfolio
- 7.1.3 Shire (Baxalta) Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 CSL
- 7.2.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 CSL Plasma Protein Therapeutics Product Portfolio
- 7.2.3 CSL Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Grifols
- 7.3.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Grifols Plasma Protein Therapeutics Product Portfolio
- 7.3.3 Grifols Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Octapharma
- 7.4.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Octapharma Plasma Protein Therapeutics Product Portfolio
- 7.4.3 Octapharma Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Kedrion
- 7.5.1 Kedrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Kedrion Plasma Protein Therapeutics Product Portfolio
- 7.5.3 Kedrion Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 LFB Group
- 7.6.1 LFB Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 LFB Group Plasma Protein Therapeutics Product Portfolio
- 7.6.3 LFB Group Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Biotest
- 7.7.1 Biotest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Biotest Plasma Protein Therapeutics Product Portfolio
- 7.7.3 Biotest Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 BPL
- 7.8.1 BPL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 BPL Plasma Protein Therapeutics Product Portfolio
- 7.8.3 BPL Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 RAAS
- 7.9.1 RAAS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 RAAS Plasma Protein Therapeutics Product Portfolio
- 7.9.3 RAAS Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 CBPO
- 7.10.1 CBPO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 CBPO Plasma Protein Therapeutics Product Portfolio
- 7.10.3 CBPO Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Hualan Bio
- 7.11.1 Hualan Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Hualan Bio Plasma Protein Therapeutics Product Portfolio
- 7.11.3 Hualan Bio Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Kamada
- 7.12.1 Kamada Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Kamada Plasma Protein Therapeutics Product Portfolio
- 7.12.3 Kamada Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Plasma Protein Therapeutics Industry Chain Analysis
- 8.2 Plasma Protein Therapeutics Product Downstream Application Analysis
- 8.2.1 Global Plasma Protein Therapeutics Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Plasma Protein Therapeutics Revenue and Forecast by Application (2020-2032)
- 8.3 Plasma Protein Therapeutics Typical Downstream Customers
- 8.4 Plasma Prote
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
